Bluejay Diagnostics (BJDX) Set to Announce Earnings on Friday

Bluejay Diagnostics (NASDAQ:BJDX) is expected to issue its results before the market opens on Friday, November 13th. Analysts expect Bluejay Diagnostics to post earnings of ($3,520.00) per share for the quarter.

Bluejay Diagnostics (NASDAQ:BJDX) last issued its earnings results on Wednesday, August 12th. The company reported ($4.48) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($14,080.00) by $14,075.52.

Bluejay Diagnostics Trading Down 0.4%

Shares of BJDX stock opened at $2.80 on Thursday. The firm has a market capitalization of $3.14 million, a PE ratio of -0.39 and a beta of 0.92. The firm has a fifty day simple moving average of $3.10 and a two-hundred day simple moving average of $7.05. Bluejay Diagnostics has a 12 month low of $1.84 and a 12 month high of $28.00.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on BJDX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Bluejay Diagnostics in a research note on Monday, September 21st. Wall Street Zen cut shares of Bluejay Diagnostics from a “hold” rating to a “sell” rating in a report on Monday, September 14th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

About Bluejay Diagnostics

Bluejay Diagnostics, Inc. is a medical technology company focused on developing rapid, point-of-care diagnostic testing solutions. The company’s technology is designed to provide healthcare professionals with timely information from blood samples, supporting clinical decision-making in settings where conventional laboratory testing may take longer. Its primary product is the Symphony system, a diagnostic platform consisting of an analyzer and disposable test cartridges. The platform is intended to measure biomarkers in whole blood and is being developed for applications including the assessment and management of serious medical conditions such as sepsis and other critical-care situations.